In populations with known or suspected high levels of isoniazid resistance, new
TB patients may receive HRE as therapy in the continuation phase as an acceptable alternative to HR.
In populations with known or suspected high levels of isoniazid resistance, new
TB patients may receive HRE as therapy in the continuation phase as an acceptable alternative to HR.